Author pages are created from data sourced from our academic publisher partnerships and public sources.
Lactobacillus rhamnosus from human breast milk shows therapeutic function against foodborne infection by multi-drug resistant Escherichia coli in mice.
The emergence of multi-drug resistant (MDR) pathogens greatly challenges the development of new drugs. Probiotics with the ability to inhibit MDR pathogens offer advantages over chemical antibiotics… Expand
Mechanisms for Lactobacillus rhamnosus treatment of intestinal infection by drug-resistant Escherichia coli.
The development of probiotics as therapeutic drugs is greatly important for the protection against threats of drug-resistant pathogen infection in both humans and animals. This study showed that… Expand
Novel Biomedical Functions of Surfactin A from Bacillus subtilis in Wound Healing Promotion and Scar Inhibition.
- L. Yan, Guanwen Liu, +11 authors J. Shi
- Chemistry, Medicine
- Journal of agricultural and food chemistry
- 15 May 2020
Surfactin produced by Bacillus subtilis is a powerful biosurfactant in food, cosmetics and pesticide industries. However, its suitability in wound healing applications is uncertain. In this article,… Expand
Therapeutic effect of Lactobacillus rhamnosus SHA113 on intestinal infection by multi-drug-resistant Staphylococcus aureus and its underlying mechanisms.
Staphylococcus aureus, especially multi-drug-resistant (MDR) pathogenic S. aureus, poses a severe threat to food safety and human health. Probiotics offer promising potential for the control of MDR… Expand
Improvement of the probiotic potential and yield of Lactobacillus rhamnosus cells using corn steep liquor
Abstract Cultivation of Lactobacillus rhamnosus using corn steep liquor provides an attractive method for comprehensive use of the major byproduct of the corn starch industry and low cost to produce… Expand